A Phase 2 Study of E6005 in Patients With Atopic Dermatitis
Latest Information Update: 09 Jun 2025
At a glance
- Drugs Lotamilast (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Dermavant Sciences; Eisai Co Ltd
Most Recent Events
- 01 Aug 2019 Results published in the Journal of Dermatological Treatment
- 25 Jan 2014 New trial record